Page last updated: 2024-08-17

mannitol and Thoracic Neoplasms

mannitol has been researched along with Thoracic Neoplasms in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Akamatsu, H; Murakami, E; Shimokawa, T; Wada, K; Yamamoto, N	1
Barnd, DL; Chianese-Bullock, KA; Deacon, DH; Eastham, S; Engelhard, VH; Galavotti, H; Gibson, J; Grosh, WW; Hibbitts, S; Merrill, P; Neese, PY; Patterson, JW; Petroni, GR; Ross, M; Slingluff, CL; Teates, D; Wiernasz, CJ; Woodson, EM; Yamshchikov, GV	1

Trials

2 trial(s) available for mannitol and Thoracic Neoplasms

Article	Year
Furosemide versus mannitol in Japanese patients with thoracic malignancy who received cisplatin-based chemotherapy using short hydration: study protocol for a randomised controlled trial. BMJ open, 2019, 12-11, Volume: 9, Issue:12 Topics: Antineoplastic Agents; Cisplatin; Clinical Trials, Phase II as Topic; Creatinine; Diuretics; Drug Therapy, Combination; Furosemide; Humans; Japan; Kidney Diseases; Mannitol; Prospective Studies; Quality of Life; Randomized Controlled Trials as Topic; Thoracic Neoplasms	2019
Clinical and immunologic results of a randomized phase II trial of vaccination using four melanoma peptides either administered in granulocyte-macrophage colony-stimulating factor in adjuvant or pulsed on dendritic cells. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003, Nov-01, Volume: 21, Issue:21 Topics: Adult; Aged; Cancer Vaccines; Dendritic Cells; Drug Administration Schedule; Female; gp100 Melanoma Antigen; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Interleukin-2; Lymph Nodes; Male; Mannitol; Melanoma; Membrane Glycoproteins; Middle Aged; Monophenol Monooxygenase; Neoplasm Proteins; Oleic Acids; Peptide Fragments; Radiography; Skin Neoplasms; Survival Analysis; T-Lymphocytes; Thoracic Neoplasms; Treatment Outcome	2003

Article

Year

Furosemide versus mannitol in Japanese patients with thoracic malignancy who received cisplatin-based chemotherapy using short hydration: study protocol for a randomised controlled trial.

BMJ open, 2019, 12-11, Volume: 9, Issue:12

Topics: Antineoplastic Agents; Cisplatin; Clinical Trials, Phase II as Topic; Creatinine; Diuretics; Drug Therapy, Combination; Furosemide; Humans; Japan; Kidney Diseases; Mannitol; Prospective Studies; Quality of Life; Randomized Controlled Trials as Topic; Thoracic Neoplasms

2019

Clinical and immunologic results of a randomized phase II trial of vaccination using four melanoma peptides either administered in granulocyte-macrophage colony-stimulating factor in adjuvant or pulsed on dendritic cells.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003, Nov-01, Volume: 21, Issue:21

Topics: Adult; Aged; Cancer Vaccines; Dendritic Cells; Drug Administration Schedule; Female; gp100 Melanoma Antigen; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Interleukin-2; Lymph Nodes; Male; Mannitol; Melanoma; Membrane Glycoproteins; Middle Aged; Monophenol Monooxygenase; Neoplasm Proteins; Oleic Acids; Peptide Fragments; Radiography; Skin Neoplasms; Survival Analysis; T-Lymphocytes; Thoracic Neoplasms; Treatment Outcome

2003